Ami Izawa, Yu Hara, Nobuyuki Horita, Suguru Muraoka, Megumi Kaneko, Ayami Kaneko, Kohei Somekawa, Momo Hirata, Yukiko Otsu, Hiromi Matsumoto, Ryo Nagasawa, Katsushi Tanaka, Sousuke Kubo, Kota Murohashi, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Nobuaki Kobayashi, Kenji Miura, Hideaki Nakajima, Takeshi Kaneko
BACKGROUND: Combining multiple tumor markers increases sensitivity for lung cancer diagnosis in the cost of false positive. However, some would like to check as many as tumor markers in the fear of missing cancer. We though to propose a panel of fewer tumor markers for lung cancer diagnosis. METHODS: Patients with suspected lung cancer who simultaneously underwent all six tests [carcinoembryonic antigen (CEA), cytokeratin-19 fragment (CYFRA), squamous cell carcinoma-associated antigen (SCC), neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), and sialyl Lewis-X antigen (SLX)] were included...
March 29, 2024: Translational Lung Cancer Research